In both human and mouse models, COX-2 inhibition can prevent the spread of CRC and CRC is associated with loss of cell-cell contact and invasion with c-Met, the hepatocyte growth factor receptor, transactivated by PGE2 via EGFR [32,33]. Here, EGFR is linked to colorectal carcinoma.